Hur farligt är potts tumor

Spara 1. Char DH. Tumors of the eye and ocular adnexa.

Pots salt

Toronto: McGraw-Hill Medical Incidence of uveal melanoma in Sweden from to Damato B. Treatment of primary intraocular melanoma. Expert review of anticancer therapy. Ocular melanoma. The Surgical clinics of North America. Time trends in the incidence of conjunctival melanoma in Sweden.

The British journal of ophthalmology. Malignant tumors of the eyelid: a population-based study of non-basal cell and non-squamous cell malignant neoplasms. Archives of ophthalmology Chicago, Ill : COMS report no. American journal of ophthalmology.

Collaborative ocular melanoma study COMS randomized trial of I brachytherapy for medium choroidal melanoma. Visual acuity after 3 years COMS report no. Clinical features of small choroidal melanoma. Current opinion in ophthalmology. Benign nevi and malignant melanomas of the choroid.

Risk factors for growth and metastasis of small choroidal melanocytic lesions. Recent developments in the management of choroidal melanoma. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category.

Transactions of the American Ophthalmological Society. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II.

Diagnostic incisional biopsies in clinically indeterminate choroidal tumours. Eye London, England. A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells.

An evaluation of enucleation in the management of uveal melanomas. Aaberg TM. Current clinical management options for uveal melanoma. Ophtalmol Clin North Am. Choroidal melanoma: natural history and management options. Cancer control : journal of the Moffitt Cancer Center.

Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment. Uveal Melanoma. Springer; chap Oct 27 ;doi No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.

BMC Cancer. Pathological and prognostic features of uveal melanomas. Canadian journal of ophthalmology Journal canadien d'ophtalmologie. Prognostic implications of monosomy 3 in uveal melanoma. May 4 ; Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.

Mutations in GNA11 in uveal melanoma. The New England journal of medicine. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science New York, NY. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.

Cancer research. Very long-term prognosis of patients with malignant uveal melanoma. Metastatic uveal melanoma. Ophthalmology clinics of North America. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.

Uveal melanoma: proton beam irradiation. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. International journal of radiation oncology, biology, physics. Singh AD. Uveal melanoma: implications of tumor doubling time.

Metastasis from untreated uveal melanomas. Seregard S. Conjunctival melanoma. Survey of ophthalmology. Brownstein S. Malignant melanoma of the conjunctiva. Layton C, Glasson W. Clinical aspects of conjunctival melanoma. Primary acquired melanosis of the conjunctiva.

Human pathology. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in eyes. The Lorenz E. Zimmerman lecture. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in consecutive patients.

Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Conjunctival malignant melanoma with xeroderma pigmentosum.

Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of cases. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.

Surgical management of conjunctival tumors. The Lynn B. McMahan Lecture. Advances in the management of conjunctival melanoma. Conjunctival melanoma metastasis diagnosed by sentinel lymph node biopsy. Conjunctival melanoma with a positive sentinel lymph node.

Sentinel lymph node biopsy for conjunctival melanoma. Ophthalmic plastic and reconstructive surgery. JAMA ophthalmology. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Adjuvant cryotherapy for focal nodular melanoma of the conjunctiva.

Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine brachytherapy.

Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites.